Medical marijuana advocates want drug reclassified

October 16, 2012 by Frederic J. Frommer

(AP)—A federal appeals court in Washington is considering whether marijuana should be reclassified from its current status as a dangerous drug with no accepted medical use.

Last year, the rejected a petition by medical marijuana advocates to change the classification—thus keeping marijuana in the same category as drugs such as heroin. The DEA concluded that there wasn't a consensus of medical opinion on using marijuana for medical purposes.

Advocates want the U.S. for the District of Columbia Circuit to force the agency to hold a hearing and conduct findings based on the scientific record.

A lawyer for the advocates told the judges on Tuesday that the DEA has misapplied the law. A government lawyer urged the court to deny the request.

Explore further: Federal government says marijuana has no accepted medical use

shares

Related Stories

Federal government says marijuana has no accepted medical use

July 13, 2011
Marijuana has been approved by many states and the nation's capital to treat a range of illnesses, but the federal government has ruled that it has no accepted medical use and should remain classified as a dangerous drug ...

US governors seek federal marijuana clearance

December 1, 2011
A pair of US governors have filed a petition asking the US federal government to allow wider use of medical marijuana by authorizing doctors to prescribe it and pharmacies to provide it.

Arkansas court upholds medical marijuana proposal

September 27, 2012
(AP)—The Arkansas Supreme Court upheld a proposed ballot measure Thursday that, if successful, would make the state the first in the more conservative southern U.S. to legalize medical marijuana.

Recommended for you

Cancer drugs' high prices not justified by cost of development, study contends

September 12, 2017
(HealthDay)— Excusing the sky-high price tags of many new cancer treatments, pharmaceutical companies often blame high research and development (R&D) costs.

Non-psychotropic cannabinoids show promise for pain relief

September 4, 2017
Some cancers love bone. They thrive in its nutrient-rich environment while gnawing away at the very substrate that sustains them, all the while releasing inflammatory substances that cause pain—pain so severe that opioids ...

Fentanyl drives rise in opioid-linked deaths in U.S.

August 31, 2017
(HealthDay)—Fentanyl, a synthetic narcotic, is a key player in America's continuing epidemic of opioid-related overdose deaths, two new studies report.

Eating triggers endorphin release in the brain

August 28, 2017
Finnish researchers have revealed how eating stimulates brain's endogenous opioid system to signal pleasure and satiety.

Cholesterol-lowering drugs may fight infectious disease

August 21, 2017
That statin you've been taking to lower your risk of heart attack or stroke may one day pull double duty, providing protection against a whole host of infectious diseases, including typhoid fever, chlamydia, and malaria.

Data revealed under FOI shows benefits of multiple sclerosis drug currently blocked by regulators

August 17, 2017
A drug that is blocked by the EU regulatory system has now been found to improve the quality of life of people with multiple sclerosis (MS), according to a study by Queen Mary University of London (QMUL).

0 comments

Please sign in to add a comment. Registration is free, and takes less than a minute. Read more

Click here to reset your password.
Sign in to get notified via email when new comments are made.